Codice QR

Thoracic radiation in combination with erlotinib—results from a phase 2 randomized trial

BackgroundRadiotherapy (RT) can be used to reduce symptoms and maintain open airways for patients with non-small cell lung cancer when systemic treatment is not sufficient. For some patients, tumor control is not achieved due to radioresistance. Concurrent inhibition of epidermal growth factor recep...

Descrizione completa

Salvato in:
Autori principali: Hanne Marte Nymoen, Tine Norman Alver, Henrik Horndalsveen, Hanne Astrid Eide, Maria Moksnes Bjaanæs, Odd Terje Brustugun, Bjørn Henning Grønberg, Vilde Drageset Haakensen, Åslaug Helland
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2024-08-01
Serie:Frontiers in Oncology
Soggetti:
non-small cell lung cancer
radioresistance
EGFR-inhibitor
erlotinib
adverse events
toxicity
Accesso online:https://www.frontiersin.org/articles/10.3389/fonc.2024.1412716/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi